BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,063 filers reported holding BAXTER INTL INC in Q3 2018. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $612 | -36.2% | 16,206 | -23.0% | 0.05% | -45.8% |
| Q2 2023 | $959 | +0.4% | 21,053 | -10.5% | 0.10% | +2.1% |
| Q1 2023 | $955 | -99.8% | 23,534 | +390.3% | 0.09% | +49.2% |
| Q4 2020 | $385,000 | -30.4% | 4,800 | -29.6% | 0.06% | -54.7% |
| Q1 2020 | $553,000 | -5.0% | 6,814 | -4.1% | 0.14% | +113.8% |
| Q2 2019 | $582,000 | -58.4% | 7,108 | -62.5% | 0.06% | -5.8% |
| Q2 2018 | $1,399,000 | -62.4% | 18,943 | -66.9% | 0.07% | -65.0% |
| Q1 2018 | $3,724,000 | +360.3% | 57,257 | +357.3% | 0.20% | +302.0% |
| Q4 2017 | $809,000 | +98.3% | 12,522 | +92.8% | 0.05% | +75.0% |
| Q3 2017 | $408,000 | -60.8% | 6,496 | -62.2% | 0.03% | -58.8% |
| Q2 2017 | $1,040,000 | +108.8% | 17,172 | +78.7% | 0.07% | +151.9% |
| Q1 2017 | $498,000 | -52.8% | 9,607 | -59.7% | 0.03% | -57.1% |
| Q4 2016 | $1,056,000 | +201.7% | 23,819 | +224.3% | 0.06% | +231.6% |
| Q3 2016 | $350,000 | -83.9% | 7,345 | -84.7% | 0.02% | -84.2% |
| Q2 2016 | $2,169,000 | +269.5% | 47,958 | +235.6% | 0.12% | +224.3% |
| Q1 2016 | $587,000 | -94.6% | 14,289 | -95.7% | 0.04% | -93.1% |
| Q3 2015 | $10,885,000 | +1726.3% | 331,369 | +3709.3% | 0.54% | +2129.2% |
| Q1 2015 | $596,000 | -84.5% | 8,699 | -83.8% | 0.02% | -88.1% |
| Q3 2014 | $3,846,000 | -53.3% | 53,589 | -52.9% | 0.20% | -45.6% |
| Q2 2014 | $8,234,000 | +296.2% | 113,885 | +303.3% | 0.37% | +150.7% |
| Q1 2014 | $2,078,000 | -69.3% | 28,238 | -72.6% | 0.15% | -72.4% |
| Q3 2013 | $6,778,000 | +195.7% | 103,185 | +211.8% | 0.54% | +97.1% |
| Q2 2013 | $2,292,000 | – | 33,089 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |